AMGN · 10-Q · 2026Q2 · Full report
Capital Expenditures Program
AMGEN INC · 2026-08-05 · Importance 71 · Surprise 82 · In source text
Amgen’s capital expenditures were $1.2 billion in the six months ended June 30, 2026, compared with $780 million in the prior-year period, primarily for new plants and manufacturing-capacity expansion. Management estimates full-year 2026 investments in capital projects of approximately $2.6 billion. The company expects existing funds, operating cash flow and financing access to support working capital, capital expenditures, debt service, dividends, repurchases and strategic acquisitions or licensing activities.
Key facts
- Cash used in investing activities during the six months ended June 30, 2026 and 2025 was primarily due to capital expenditures of $1.2 billion and $780 million, respectively, including construction costs for new plants and expansion of manufacturing capacity. source
- We currently estimate full year 2026 investments in capital projects to be approximately $2.6 billion. source
- Purchases of property, plant and equipment (capital expenditures) for six months ended June 30, 2026: $(1,225) million source
- Net cash used in investing activities for six months ended June 30, 2026: $(1,285) million source
- Property, plant and equipment, net as of June 30, 2026: $8,547 million and accumulated depreciation and amortization of property, plant and equipment was $9.4 billion as of June 30, 2026 source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | committed | -2.3% | We currently estimate full year 2026 investments in capital projects to be approximately $2.6 billion. |
| assets | positive | committed | +2.3% | We currently estimate full year 2026 investments in capital projects to be approximately $2.6 billion. |
| cash | negative | realized | -1.3% | Net cash used in investing activities for six months ended June 30, 2026: $(1,285) million |
| cash | negative | realized | -1.3% | Cash used in investing activities during the six months ended June 30, 2026 and 2025 was primarily due to capital expenditures of $1.2… |
| assets | positive | realized | +1.3% | Cash used in investing activities during the six months ended June 30, 2026 and 2025 was primarily due to capital expenditures of $1.2… |
| assets | positive | realized | — | Property, plant and equipment, net as of June 30, 2026: $8,547 million and accumulated depreciation and amortization of property, plant… |